Retrospective Cohort Study of Novel Oral Agents Lenalidomide and Duvelisib For Relapsed or Refractory Mycosis Fungoides and Sézary Syndrome
Published: 12 November 2024| Version 1 | DOI: 10.17632/nh69skddb7.1
Contributor:
Omar ElghawyDescription
Supplemental Figure for Manuscript
Files
Categories
Dermatology, Lymphoma, Cutaneous T-Cell Lymphoma, Mycosis Fungoides